life), individual (e.g., coping style, stress appraisal, physical health) and relationship (e.g., decreased relationship satisfaction, intimacy or functioning) factors Couper et al., 2006; Harden et al., 2013; Hyde et al., 2018; Wootten, Abbott, Farrell, Austin, & Klein, 2014) .
In order to facilitate and better target psychological interventions and supportive care in the oncology setting to those who are most likely to benefit, it is necessary to first identify who is distressed and from this refer to an appropriate level of psychosocial care (Hutchison, Steginga, & Dunn, 2006) . This approach ensures valuable and often scarce resources are directed to where they are most needed. Standards for optimal oncology care advise that screening for distress and referral to evidence-based services is needed as part of routine care (Holland, Watson, & Dunn, 2011) . Ultra-short screening measures (<5 items, <2 min to complete) are more easily integrated with the demands of clinical care settings (time-and cost-efficient), help to promote universal access to psychological services and are recommended as an initial step to identify patients who may be distressed (Vodermaier, Linden, & Siu, 2009 ). The Distress Thermometer (DT) is widely used with cancer patients as a brief screen to detect overall emotional distress (Lazenby, Tan, Pasacreta, Ercolano, & McCorkle, 2015; Vodermaier et al., 2009 ).
Meta-analysis of validation studies and systematic reviews support an optimal DT cut-off ≥4 to indicate at least moderate distress requiring more in-depth assessment, intervention or referral (Butow et al., 2015; Ma et al., 2014; Mitchell, 2007; Vodermaier et al., 2009) . Although use of the DT and its validity is well established for cancer patients including men diagnosed with PCa (Chambers, Girgis, et al., 2014; Roth et al., 1998) , the optimal approach for detecting heightened distress in the partners of these men is unclear.
A rapid review conducted for the purposes of this study found that quantitative studies with partners or caregivers of adult cancer patients which included the DT as a measure to assess distress (predictor or outcome) typically used a DT cut-off ≥4 (Chambers et al., 2012; Chambers, Girgis, et al., 2014; Chatterton et al., 2015; Fujinami et al., 2015; Howell et al., 2011; Hughes, Sargeant, & Hawkes, 2011; Hutchison et al., 2011; Morris et al., 2015; Trad et al., 2015) or ≥5 (Badr, Gupta, Sikora, & Posner, 2014; Feiten et al., 2013; Goebel, von Harscher, & Mehdorn, 2011; Goldzweig, Rottenberg, Peretz, & Baider, 2015; Halkett et al., 2016; Juarez, Ferrell, Uman, Podnos, & Wagman, 2008; Long et al., 2016; Ugalde, Krishnasamy, & Schofield, 2014; Weide et al., 2012; Zwahlen, Hagenbuch, Jenewein, Carley, & Buchi, 2011) . However, systematic reviews and meta-analyses of studies validating the DT or brief screening measures in the cancer context are silent with regard to the optimal DT cut-off to identify distress in partners/caregivers. To our knowledge, three studies (Bevans et al., 2011; Hawkes, Hughes, Hutchison, & Chambers, 2010; Zwahlen, Hagenbuch, Carley, Recklitis, & Buchi, 2008) have validated the DT in family members or caregivers using receiver operating characteristics (ROC) analysis. Zwahlen et al. (2008) compared the DT to the subscales of the Hospital and Anxiety Depression Scale (HADS) and recommended it for use in clinical assessment of family members of outpatients with cancer. A DT cut-off of 3-4 or 4-5 was proposed as optimal for sensitivity (anxiety and depression ≥0.86) and a cutoff of 4-5 for acceptable specificity (anxiety 0.71, depression 0.68).
By comparison, Hawkes et al. (2010) compared the DT to the HADS in carers of cancer patients who contacted a cancer helpline and recommended a DT cut-off of ≥6. However, although discriminant ability of the DT (AUC 0.70) and sensitivity (0.77) was acceptable, specificity was poor (0.48). Bevans et al. (2011) compared the DT to the Brief Symptom Inventory-18 in caregivers of patients undergoing allogeneic hematopoietic stem cell transplant. Discriminant ability of the DT was poor (AUC 0.61), and no clear consensus was obtained on an appropriate DT cut-off.
Cancer-specific distress is also an important outcome for caregivers of cancer patients. For example, in a study of 427 female partners of prostate cancer survivors (2-4 years post-treatment) who were followed up over 24 months, higher caregiver burden and more threat appraisals were associated with increased distress, anxiety, depression, and cancer-specific distress over time (as measured by the HADS and Impact of Events Scale-Revised There is a need for guidance regarding diagnostic utility of the DT and its appropriateness for use in oncology and community and primary care settings with partners of cancer patients, and in particular partners of men with PCa. Accordingly, we undertook ROC analyses in two cohorts of women whose partners had been previously diagnosed with PCa. Specifically, we assessed sensitivity and specificity of the DT when compared to general (HADS) and cancer-specific (IES-R) distress, and performance of the DT over time compared to these measures.
| ME THOD

| Participants
| Study 1
Participants were 189 partners of men with localised PCa (recruited around diagnosis) who had chosen or received surgical treatment (Chambers et al., 2008 . In brief, mean age of partners was 59.8 years (SD = 7.4; range 40.0-75.0). Most (96%) partners were married (length of relationship M = 32.5 years, SD = 11.8, range = 0.5-51.0) and 30% had children living at home. Approximately half (48%) had a university degree or technical certificate, and 40% had a gross household income below AUD$60,000 per annum.
| Study 2
Participants were 460 female partners of men previously diagnosed with PCa (2-4 years post-treatment), identified through an existing TA B L E 1 Summary of area under the ROC curve analyses comparing the DT to the HADS and IES-R The optimal DT cut-off is given by the maximum value of the Youden Index which measures the vertical distance from the line of equality to the ROC curve. The optimal DT cut-off is given by the point that is closest to the ROC (0, 1).
d
Positive likelihood ratio=Sensitivity/(1-Specificity).
e Negative likelihood ratio=(1-Sensitivity)/Specificity.
TA B L E 1 (Continued) study . In brief, partners were mean age 62.8 years (SD = 8.0; range = 29.5-83.0); 96% were married; mean length of relationship was 36.3 years (SD = 12.8; range = 2.1-59.5);
21% had children living at home. Under half (44%) had a university degree or technical certificate; 60% had a gross annual household income below AUD$60,000.
| Procedure
Participants 
| Measures
| Distress thermometer
The DT is widely used as an ultra-brief screening measure to assess general psychological distress in patients diagnosed with cancer (Mitchell, 2007; National Comprehensive Cancer Network, 2013) .
Partners reported the level of distress they were currently experiencing (within the past week including the day on which they were assessed) on a single 11-point scale, scored 0 no distress to 10 extreme distress.
| Hospital Anxiety and Depression Scale
The 14 across all time points in both cohorts. In the current study, cut-off scores ≥8 on HADS-A and HADS-D subscales (Zigmond & Snaith, 1983 ) and ≥11 on HADS-T (Vodermaier & Millman, 2011) were used to indicate participants with some level of emotional distress.
| Impact of Events Scale-Revised
The 22-item IES-R (Horowitz, Wilner, & Alvarez, 1979; Weiss et al., 1997 ) measured cancer-specific distress, specifically partner's experience of intrusive or avoidant thinking and hyperarousal regarding the man's PCa in the past week (Study 2 only). Items were scored on 5-point scales from 0 not at all to 4 extremely; higher scores indicate more cancer-specific distress (range 0-88). Internal consistency over time was excellent (α = 0.94-0.96). A cut-off score ≥33 was used in the current study to indicate high cancer-specific distress (Creamer, Bell, & Failla, 2003) .
| Statistical analyses
Receiver operating characteristics (ROC) analysis evaluated diagnos- and an AUC of 0.5 indicates that the probability of the DT detecting a person experiencing distress (as determined by the HADS/IES-R scales) is no greater than chance (Metz, 1978) . For the current study, an AUC of 0.60-0.69 is considered to have poor discriminating ability, 0.70-0.79 is fair, 0.80-0.89 is good, and 0.90 or above is excellent (Ma et al., 2014; Metz, 1978) . Sensitivity (proportion of partners correctly identified as distressed) and specificity values (proportion of partners correctly identified as not distressed) were calculated for each of the DT scale points. The optimal DT thresholds were then selected according to two methods: the Youden Index (the cut-off is selected as the point on the AUC that is farthest from chance, corresponding to the maximum value of (sensitivity + specificity -1; Youden, 1950) , and the point on the ROC closest to (0,1) indicating perfect classification of partners with and without clinical distress. Table 1 shows the optimal DT cut-offs according to the two selection methods along with the AUC, sensitivity, specificity, the percentage correctly classified, and the positive and negative likelihood ratios.
| RE SULTS
3.1 | Study 1
| Psychological distress
Distress Thermometer scores at baseline (M = 2.79, SD = 2.66), 3 months (M = 1.87, SD = 2.47), 6 months (M = 1.72, SD = 2.14)
and 12 months (M = 1.52, SD = 2.06) showed that on average, partner distress decreased after the first 6 months. The proportion of partners who would be considered distressed using DT cut-offs suggested for caregivers of patients with cancer in prior research was identified. Based on a DT cut-off ≥4 (Zwahlen et al., 2008) , 23.3% of partners were distressed at baseline, and this reduced to 14.5% and 14.2% at 3 and 6 months (by which time most men had received treatment), respectively, and decreased further to 11.5% at 12 months. With a DT cut-off ≥5 (Zwahlen et al., 2008) , 18.5% were identified as distressed at baseline and the proportion of partners who were distressed decreased over time (3 months 12.6%; 6 months 9.0%; 12 months 7.4%). This pattern was also consistent with a DT cut-off ≥6 (Hawkes et al., 2010) , with 12.7% of partners identified as distressed at baseline with subsequent declines in these numbers (3 months 8.2%; 6 months 5.2%; 12 months 4.1%).
| Diagnostic accuracy of the DT compared to the HADS
Comparing the DT to HADS-T at baseline, the AUC was 0.84 (95% CI 0.78-0.90) with an optimal DT cut-off of ≥4 according to both classification methods (Table 1) . The corresponding values for ROC curves for the HADS-T at 3, 6 and 12 months remained fairly stable, with a decrease in the threshold to ≥3 at 3 and 6 months and then to ≥2 at 12 months. Sensitivity of the DT compared with HADS-T across the time points was low (61%-69%); however, specificity was higher (73%-88%). A similar pattern of results to the HADS-T was noted for the HADS-A from baseline to 12 months, except for two different optimal DT cut-off points being identified at 3 months of ≥3 (Youden Index) and ≥2 (point on the ROC closest to (0,1)). Both cut-off points had low sensitivity (61.4% and 68.2%) and higher specificity (83.5% and 73.0%). and optimal cut-offs were determined as ≥5 (Youden Index) or ≥3 (the point on the ROC closest to (0,1)). Both cut-offs had very low sensitivity (50.0% and 58.3%); however, specificity was higher (88.4% and
73.5%). Diagnostic accuracy of the DT compared to the HADS-D at
3 months was similar to the 6-month and 12-month time points, although the optimal DT cut-offs lowered to ≥2 and ≥3 respectively.
| Study 2
| Psychological distress
Mean scores on the DT suggest that partner distress remained of partners as distressed at baseline and this proportion remained relatively stable over time (6 months 17.5%, 12 months 17.2%, 18 months 18.0%, 24 months 16.7%). A DT cut-off ≥5 (Zwahlen et al., 2008) classified approximately 10% of partners as distressed over time (baseline 9.8%, 6 months 11.7%, 12 months 11.1%, 18 months 10.8%, 24 months 10.6%), and a DT cut-off ≥6 (Hawkes et al., 2010) identified less than 10% of partners as distressed (baseline 6.1%, 6 months 7.3%, 12 months 8.6%, 18 months 8.0%, 24 months 7.0%).
| Diagnostic accuracy of the DT compared to the HADS
For the HADS-T at baseline, a cut-off score of ≥2 yielded the optimal ratio of sensitivity (82.7%) and specificity (75.3%) with an AUC of 0.85 (95% CI 0.81-0.89). Accuracy of the DT compared to the HADS-T remained high (AUCs ≥0.85) at 6, 12 and 18 months and decreased slightly at 24 months (AUC =0.81, 95% CI 0.76-0.87).
However, sensitivity reduced at 6, 12 and 18 months and specificity increased in the same time frame (Table 1) . At the 24-month assessment, sensitivity (77.1%) and specificity (73.0%) were more balanced. The optimal DT cut-off was ≥3 at 6, 12 and 18 months and reduced to ≥2 at 24 months.
Compared to the HADS-A subscale, the DT initially showed a cut-point ≥3 at baseline (and again at 12 months) as providing the best balance of sensitivity (73.1%) and specificity (79.8%). However, the optimal DT cut-point reduced to ≥2 at 6, 18 and 24 months (Table 1 ). An alternative DT cut-off ≥1 was suggested at 24 months (Youden) and although sensitivity was high (90.2%), specificity was poor (59.2%). All AUCs were >0.80 supporting good accuracy overall across time for the DT compared to the anxiety subscale ( Table 1 ).
The AUC score at baseline (0.87, 95% CI 0.82-0.92) showed good accuracy for the DT as compared to the HADS-D subscale, with a cutoff ≥4 providing optimal balance between sensitivity (79.5%) and specificity (82.3%). At 6, 12 and 24 months, the DT cut-off providing the best balance for sensitivity and specificity reduced to ≥3 (ROC (0,1)) (Table 1) . A cut-point ≥3 (Youden) was also identified for 18 months (AUC =0.92, 95% CI 0.88-0.95); however, a cut-off ≥4 (ROC (0,1)) gave a better balance between sensitivity (86.2%) and specificity (82.8%).
For all remaining time points, the DT showed good accuracy with AUCs ranging from 0.81 (6 months) to 0.89 (24 months; Table 1 ).
| Diagnostic accuracy of the DT compared to the IES-R
At baseline, the AUC was 0.83 (95% CI 0.75-0.91) with an optimal DT cut-off of ≥3 (Table 1) . Although accuracy of the DT across time remained high (AUCs ranged from 0.87-0.91), the optimal DT cut-off was not consistent over time. At 6 months, a DT cut-off ≥5 provided a good balance between sensitivity (85.0%) and specificity (85.8%), and at 12 months, this reduced to ≥3 (Youden Index) or ≥4 (ROC (0,1)), increased to ≥5 (Youden Index) or ≥4 (ROC (0,1)) at 18 months and remained at ≥5 at 24 months. Over time, depending on the optimal DT cut-off identified, sensitivity and specificity values ranged from 71% to 95% and 71% to 87% respectively.
| D ISCUSS I ON
In the current study, overall diagnostic accuracy of the DT in female partners of men with PCa was inconsistent. Although AUC scores suggested that performance of the DT compared to the HADS (AUC range 0.71-0.92) and IES-R (AUC range 0.83-0.94) was acceptable, other diagnostic indicators varied and were context-dependent. Specifically, when performance of the DT was compared to the HADS within and between studies, optimal DT cut-offs to detect partner distress ranged from ≥2 to ≥5; against the IES-R, optimal DT cut-offs ranged from ≥3 to ≥5, with no clear pattern emerging to indicate a single optimal DT cut-point. Close to the time of the man's diagnosis and treatment, the sensitivity of the DT in detecting partners' distress was consistently lower than specificity, regardless of the DT cut-off used. When men were beyond treatment and well into survivorship, sensitivity was either higher than specificity or each value was more equally balanced. In the context of screening for a common condition such as distress, high sensitivity is needed to avoid overlooking partners who are in fact distressed (Youngstrom, 2014) . However, unless the measure has reasonable specificity, there is a risk of over-diagnosis of distress resulting in unnecessary treatment or referral and impact on already limited availability of supportive care professionals and resources in clinical care. Thus, use of the DT alone to detect female partners in need of further assessment or psychological intervention appears problematic and more comprehensive screening measures may be needed.
Ultra-short screening measures with 2-4 items tend to have better sensitivity than single-item measures (Mitchell & Coyne, 2007) although, similar to the DT, specificity may be moderate and evaluation with a more in-depth measure required (Lazenby et al., 2015; Mitchell & Coyne, 2007 (Pirl et al., 2014) . The PHQ-4 is also increasingly being utilised in cross-sectional or longitudinal predictive studies to measure distress as a predictor or outcome in partners (e.g., Ernst et al., 2017; Haun et al., 2014; Pankrath et al., 2018) and caregivers (e.g., Oh, 2017; of cancer patients. However, no studies have examined the diagnostic utility of the PHQ-4 compared to other ultrashort or more in-depth screening measures such as the HADS in partners or caregivers of cancer patients. This is an area worthy of further investigation.
In some studies of patients with cancer, distress as measured by the DT has aligned more closely with the anxiety subscale of the HADS (Gil, Grassi, Travado, Tomamichel, & Gonzalez, 2005) .
To address this, researchers have proposed the use of additional emotion thermometers (e.g., mood thermometer) to supplement the DT and increase sensitivity to better detect multiple domains of distress (e.g., depression) (Gil et al., 2005; Mitchell, 2007; Vodermaier et al., 2009 ). For instance, Mitchell and colleagues proposed the use of a 5-item emotion thermometers tool covering distress, anxiety, depression, anger and need for help and showed that sensitivity of the DT in detecting distressed patients with cancer can be improved by including these additional thermometers (Mitchell, Baker-Glenn, Park, Granger, & Symonds, 2010) . For partners or caregivers, there may also be other dimensions of distress such as caregiver burden that warrant inclusion. However, as is clear from the current study, suitable approaches for patients may not transfer directly to partners and a new approach may be needed potentially building on the work of Mitchell and colleagues Mitchell, Baker-Glenn, Park, et al., 2010) to incorporate partner-or caregiver-specific issues.
Overall, our results are not consistent with other validations of the DT with caregivers/family members in cancer (Hawkes et al., 2010; Zwahlen et al., 2008) . Of note, these previous studies relied on single sample, cross-sectional designs within which temporal and contextual variations will not be elucidated. A strength of the current study is the inclusion of two cohorts of partners prospectively assessed at different time points in the cancer trajectory. A limitation of the current study is the small number of female partners who were identified as depressed (~8%) resulting in wide confidence intervals around the AUC scores and potentially increasing uncertainty regarding optimal thresholds (Chambers, Girgis, et al., 2014) . As noted, there may also be other dimensions of distress that are more salient for partners (e.g., caregiver 
